NULASTA owner Contact Information online
from Amgen Inc.
NULASTA
US serial number:85030988
Application filling date:May 05, 2010
Register:Principal
Mark type:Trademark
Status:Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Status date:Jun. 16, 2014
Publication date:Mar. 15, 2011
Abandoned date:Jun. 16, 2014
Standard character claim:Yes. The mark consists of standard characters without claim to any particular font style, size, or color.
Mark drawing type:4 - STANDARD CHARACTER MARK
Goods and services:For: Pharmaceutical preparations for stimulating white blood cell production
International Class(es): 005- Primary Class
U.S Class(es): 006,018,044,046,051,052
Class Status: ACTIVE
Basis: 1(b)
Services:Pharmaceutical preparations for stimulating white blood cell production
Current owner owner name:Amgen Inc.
Current owner owner address:One Amgen Center Drive
Thousand Oaks,
CALIFORNIA
UNITED STATES
91320-179
Current owner legal entity type:CORPORATION
Current owner state or country:DELAWARE
Attorney name:Mark I. Feldman, Christina L. Martini
Attorney email:ch.tm@dlapiper.com
Attorney docket number:211492-24017
Attorney email authorized:Yes
Correspondent name address:MARK I. FELDMAN, CHRISTINA L. MARTINI
DLA PIPER LLP (US)
PO BOX 64807
CHICAGO,
ILLINOIS
UNITED STATES
60664-0807
Correspondent phone:312 368 4000
Correspondent email:ch.tm@dlapiper.com
Correspondent fax:312 236 7516
Correspondent email authorized:Yes
Trademark staff tm attorney:LEE, JANET H
Trademark staff law office assigned NULASTA:LAW OFFICE 102
Latest trademarks
Popular owners
Glaxo Group Limited (174) JOHNSON & JOHNSON (136) Novartis AG (134) Millennium Pharmaceuticals, Inc. (54) Eli Lilly and Company (51) Windmill Health Products, LLC (47) Bayer Aktiengesellschaft (44) SANOFI (43) Pfizer Inc. (41) Wyeth LLC (41) Bristol-Myers Squibb Company (35) Forest Laboratories, Inc. (34) Vital Health Pharmaceuticals, Inc. (31) S. C. Johnson & Son, Inc. (29) Primary Investments Group Limited (28) MERCK SHARP & DOHME CORP. (27) Futurebiotics, LLC (26) MONSTER ENERGY COMPANY (19) Scott Riddell (17) Biocept, Inc. (16)Popular publication dates
Mar. 15, 2011 Mar. 08, 2011 Mar. 22, 2011 Nov. 16, 2010 Mar. 29, 2011 Apr. 19, 2011 Apr. 12, 2011 Oct. 19, 2010 Oct. 26, 2010 Apr. 26, 2011 Feb. 15, 2011 Oct. 05, 2010 Oct. 12, 2010 Sep. 21, 2010 Jan. 25, 2011 Jan. 11, 2011 Feb. 22, 2011 Nov. 23, 2010 Sep. 28, 2010 Apr. 05, 2011Similar brands
